FFCP PHASE1:Mm9::chr12:115596491..115596503,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=|HGNC=|MCL_coexpression_id=2773|UniProt=|association_with_transcript=-62bp_to_ENSMUST00000125484_5end|description=CAGE_peak_2_at_ENSMUST00000125484_5end|id=chr12:115596491..115596503,-|ontology_enrichment_celltype=CL:0000553!1.66e-09!6;CL:0000556!1.66e-09!6|ontology_enrichment_celltype_v019_2=CL:0000553,3.14e-25,6;CL:0000556,3.14e-25,6;CL:0000050,7.93e-17,9;CL:0000839,1.24e-11,13;CL:0000763,1.96e-09,16;CL:0002027,5.92e-09,3;CL:0002006,5.92e-09,3;CL:0002024,5.92e-09,3;CL:0002031,2.50e-08,25;CL:0000049,6.33e-08,19;CL:0000945,4.83e-07,1;CL:0000236,4.83e-07,1;CL:0000826,4.83e-07,1|ontology_enrichment_disease=|ontology_enrichment_disease_v019_2=|ontology_enrichment_uberon=UBERON:0002193!1.87e-07!48;UBERON:0002465!2.13e-07!3;UBERON:0007823!5.68e-07!5|ontology_enrichment_uberon_v019_2=UBERON:0002465,2.34e-18,3;UBERON:0002193,1.06e-13,48;UBERON:0002405,1.06e-13,48;UBERON:0001962,1.88e-12,2;UBERON:0001961,1.88e-12,2;UBERON:0001744,1.88e-12,2;UBERON:0002371,1.96e-09,16;UBERON:0002106,2.68e-09,6;UBERON:0004457,2.68e-09,6;UBERON:0000042,2.68e-09,6;UBERON:0004854,2.68e-09,6;UBERON:0009034,2.68e-09,6;UBERON:0002095,2.68e-09,6;UBERON:0004782,2.68e-09,6;UBERON:0003281,2.68e-09,6;UBERON:0009664,2.68e-09,6;UBERON:0002296,2.68e-09,6;UBERON:0005602,2.68e-09,6;UBERON:0001179,2.68e-09,6;UBERON:0006293,2.68e-09,6;UBERON:0002390,1.13e-07,45;UBERON:0003061,1.13e-07,45;UBERON:0000029,1.38e-07,1;UBERON:0001097,1.38e-07,1;UBERON:0003968,1.38e-07,1;UBERON:0001467,1.38e-07,1;UBERON:0003199,4.21e-07,1;UBERON:0001474,7.99e-07,22;UBERON:0004765,7.99e-07,22;UBERON:0001434,7.99e-07,22|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,6.32908547449759,4.45445588257617,0,26.1833597247337,6.17014951225825,5.51706547337439,0.340173160604279,0,0,2.3998863419011,3.21172993494038,0,0,0,0.380046838912748,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.51673909086605,0,0.672187598284928,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.421333260395256,0,0,0,0,0,0,0,0,0,0,0.68510327831436,15.7952109024775,0,0,0,0,0,0.117588707135705,0,0,0.433798070759735,0.884610551949874,0,0.662524555381181,0.969750506270444,0,0,0,6.38642638021478,0,0,0,0,0,0,0,0,0,0,0,0.248813941220186,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.162137619091711,0,0.219550115291051,0,0,0,0,4.23120906661671,0,0,0,0,0,0,0,0,0,0,0,0,0.864552199498777,0.199141273254367,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.923765950833023,0,0,0,0,0,0,0,0.157635144106191,0.221464689648775,0,0.163863314715738,0,0.289298117163023,0,0,0,0.275936746304732,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.356497378384721,0,1.05418608574999,0,0,0,0,0,0,0,0,0,0,0,0.882113592219848,0,0,0,0,0,0.582961673259701,0,9.56876932467975,0,0,0.941842285023455,1.36694227721025,1.60144721244566,0,0,0,0,0,0,0,0,0,0,0,0.26175594198403,0,0.621339313086926,0,0,0,0,0,0,0,0,0,0,0,0.632022241256357,0,0,0,0,0,0,0,0,0.0762068066549998,0,0,0.288635524920988,0.584384510907845,0,0,0,0,0.579568782096571,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.231867835620421|short_description=p2@ENSMUST00000125484}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene= | |||
|HGNC= | |||
|MCL_coexpression_id=2773 | |||
|TSSclassifier=NA | |||
|UniProt= | |||
|association_with_transcript=-62bp_to_ENSMUST00000125484_5end | |||
|cluster_id=chr12:115596491..115596503,- | |||
|description=CAGE_peak_2_at_ENSMUST00000125484_5end | |||
|id=chr12:115596491..115596503,- | |||
|ontology_enrichment_celltype=CL:0000553!1.66e-09!6;CL:0000556!1.66e-09!6 | |||
|ontology_enrichment_celltype_v019_2=CL:0000553,3.14e-25,6;CL:0000556,3.14e-25,6;CL:0000050,7.93e-17,9;CL:0000839,1.24e-11,13;CL:0000763,1.96e-09,16;CL:0002027,5.92e-09,3;CL:0002006,5.92e-09,3;CL:0002024,5.92e-09,3;CL:0002031,2.50e-08,25;CL:0000049,6.33e-08,19;CL:0000945,4.83e-07,1;CL:0000236,4.83e-07,1;CL:0000826,4.83e-07,1 | |||
|ontology_enrichment_disease= | |||
|ontology_enrichment_disease_v019_2= | |||
|ontology_enrichment_uberon=UBERON:0002193!1.87e-07!48;UBERON:0002465!2.13e-07!3;UBERON:0007823!5.68e-07!5 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0002465,2.34e-18,3;UBERON:0002193,1.06e-13,48;UBERON:0002405,1.06e-13,48;UBERON:0001962,1.88e-12,2;UBERON:0001961,1.88e-12,2;UBERON:0001744,1.88e-12,2;UBERON:0002371,1.96e-09,16;UBERON:0002106,2.68e-09,6;UBERON:0004457,2.68e-09,6;UBERON:0000042,2.68e-09,6;UBERON:0004854,2.68e-09,6;UBERON:0009034,2.68e-09,6;UBERON:0002095,2.68e-09,6;UBERON:0004782,2.68e-09,6;UBERON:0003281,2.68e-09,6;UBERON:0009664,2.68e-09,6;UBERON:0002296,2.68e-09,6;UBERON:0005602,2.68e-09,6;UBERON:0001179,2.68e-09,6;UBERON:0006293,2.68e-09,6;UBERON:0002390,1.13e-07,45;UBERON:0003061,1.13e-07,45;UBERON:0000029,1.38e-07,1;UBERON:0001097,1.38e-07,1;UBERON:0003968,1.38e-07,1;UBERON:0001467,1.38e-07,1;UBERON:0003199,4.21e-07,1;UBERON:0001474,7.99e-07,22;UBERON:0004765,7.99e-07,22;UBERON:0001434,7.99e-07,22 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,6.32908547449759,4.45445588257617,0,26.1833597247337,6.17014951225825,5.51706547337439,0.340173160604279,0,0,2.3998863419011,3.21172993494038,0,0,0,0.380046838912748,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.51673909086605,0,0.672187598284928,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.421333260395256,0,0,0,0,0,0,0,0,0,0,0.68510327831436,15.7952109024775,0,0,0,0,0,0.117588707135705,0,0,0.433798070759735,0.884610551949874,0,0.662524555381181,0.969750506270444,0,0,0,6.38642638021478,0,0,0,0,0,0,0,0,0,0,0,0.248813941220186,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.162137619091711,0,0.219550115291051,0,0,0,0,4.23120906661671,0,0,0,0,0,0,0,0,0,0,0,0,0.864552199498777,0.199141273254367,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.923765950833023,0,0,0,0,0,0,0,0.157635144106191,0.221464689648775,0,0.163863314715738,0,0.289298117163023,0,0,0,0.275936746304732,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.356497378384721,0,1.05418608574999,0,0,0,0,0,0,0,0,0,0,0,0.882113592219848,0,0,0,0,0,0.582961673259701,0,9.56876932467975,0,0,0.941842285023455,1.36694227721025,1.60144721244566,0,0,0,0,0,0,0,0,0,0,0,0.26175594198403,0,0.621339313086926,0,0,0,0,0,0,0,0,0,0,0,0.632022241256357,0,0,0,0,0,0,0,0,0.0762068066549998,0,0,0.288635524920988,0.584384510907845,0,0,0,0,0.579568782096571,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.231867835620421 | |||
|short_description=p2@ENSMUST00000125484 | |||
}} |
Latest revision as of 20:13, 4 August 2015
Short description: | p2@ENSMUST00000125484 |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_2_at_ENSMUST00000125484_5end |
Coexpression cluster: | MCL_coexpression_mm9:2773 |
Association with transcript: | -62bp_to_ENSMUST00000125484_5end |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
megakaryocyte progenitor cell | 3.14e-25 | 6 |
megakaryocyte | 3.14e-25 | 6 |
megakaryocyte-erythroid progenitor cell | 7.93e-17 | 9 |
myeloid lineage restricted progenitor cell | 1.24e-11 | 13 |
myeloid cell | 1.96e-09 | 16 |
CD9-positive, CD41-positive megakaryocyte cell | 5.92e-09 | 3 |
Kit-positive, CD34-negative megakaryocyte erythroid progenitor cell | 5.92e-09 | 3 |
Kit-positive megakaryocyte progenitor cell | 5.92e-09 | 3 |
hematopoietic lineage restricted progenitor cell | 2.50e-08 | 25 |
common myeloid progenitor | 6.33e-08 | 19 |
lymphocyte of B lineage | 4.83e-07 | 1 |
B cell | 4.83e-07 | 1 |
pro-B cell | 4.83e-07 | 1 |
Ontology term | p-value | n |
---|---|---|
lymphoid system | 2.34e-18 | 3 |
hemolymphoid system | 1.06e-13 | 48 |
immune system | 1.06e-13 | 48 |
gut-associated lymphoid tissue | 1.88e-12 | 2 |
mucosa-associated lymphoid tissue | 1.88e-12 | 2 |
lymphoid tissue | 1.88e-12 | 2 |
bone marrow | 1.96e-09 | 16 |
spleen | 2.68e-09 | 6 |
cavity lining | 2.68e-09 | 6 |
serous membrane | 2.68e-09 | 6 |
gastrointestinal system mesentery | 2.68e-09 | 6 |
stomach region | 2.68e-09 | 6 |
mesentery | 2.68e-09 | 6 |
gastrointestinal system serosa | 2.68e-09 | 6 |
mesentery of stomach | 2.68e-09 | 6 |
gut mesentery | 2.68e-09 | 6 |
dorsal mesentery | 2.68e-09 | 6 |
dorsal mesogastrium | 2.68e-09 | 6 |
peritoneal cavity | 2.68e-09 | 6 |
spleen primordium | 2.68e-09 | 6 |
hematopoietic system | 1.13e-07 | 45 |
blood island | 1.13e-07 | 45 |
lymph node | 1.38e-07 | 1 |
axillary lymph node | 1.38e-07 | 1 |
peripheral lymph node | 1.38e-07 | 1 |
shoulder | 1.38e-07 | 1 |
egg chamber | 4.21e-07 | 1 |
bone element | 7.99e-07 | 22 |
skeletal element | 7.99e-07 | 22 |
skeletal system | 7.99e-07 | 22 |